News

NIH office to phase out HIV guidelines by next year
The National Institutes of Health office responsible for issuing federal guidelines related to treatment of HIV and AIDS ...
FDA approves new twice-yearly HIV shot. What to know
The FDA approved Gilead's HIV prevention drug lenacapavir, a twice-a-year injectable medication that clinical trials show ...
Here’s what everyone should know about this new HIV prevention shot
Yeztugo, approved by the FDA, was highly effective in two randomized trials. It costs $28,218 per year, and people have to be ...
New HIV drug’s global access hangs in the balance
HIV and global health activists say the deployment of Gilead’s twice-a-year HIV prevention shot is the world’s best chance to ...
U.S. approves first-ever biannual shot to prevent HIV, but getting it might be hard
WASHINGTON — The U.S. has approved the world’s only twice-a-year shot to prevent HIV, the first step in an anticipated global ...
HIV: Supercharged Vaccine Could Protect Well With Just One Dose
The approach employed by the research team could be used against other diseases—including COVID-19 and influenza.
HIV Drug Potentially Effective Against Diabetic Eye Disease
The drug, lamivudine, appears to improve vision that’s being threatened by diabetic macular edema (DME), an eye condition in ...
Ray of hope for HIV patients, as Hyderabad-based pharma giants secure nod for game-changing HIV drug
Indian firms have secured rights to produce Lenacapavir, a twice-yearly HIV injection, making treatment easier and affordable ...
Science Daily6h
HIV is surging in over-50s—But campaigns still target the young
HIV is surging among adults over 50 in sub-Saharan Africa, yet prevention and treatment campaigns still focus mainly on the ...
Country music singer opens up about HIV status, sexuality with release of new song
In a song out during Pride month and ahead of HIV testing day on June 27, a Nashville country singer discusses his own ...